Corcept Therapeutics (CORT) Change in Cash (2010 - 2026)
Corcept Therapeutics (CORT) posted Change in Cash of $2.3 million for Q2 2026, up 119.57% sequentially from -$11.8 million in Q1 2026, and down 82.2% YoY from $12.9 million in Q2 2025.
Corcept Therapeutics (CORT) Change in Cash (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Change in Cash for 17 years, with the latest figure at $2.3 million in Q2 2026.
- Quarterly Change in Cash fell 82.2% year-over-year to $2.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.3 million (up 132.09% YoY) and the FY2025 annual result came in at -$7.2 million, up 9.08% from the prior year.
- Change in Cash advanced to $2.3 million in Q2 2026 per CORT's latest filing, from -$11.8 million in the prior quarter.
- Over five years, Change in Cash peaked at $233.6 million in Q1 2023 and troughed at -$127.6 million in Q2 2023.
- A 5-year average of $1.9 million and a median of -$1.2 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2023: Change in Cash soared 2107.68% in 2022, then sank 506.64% in 2023.
- Over 5 years, Change in Cash stood at $16.1 million in 2022, then surged by 47.65% to $23.8 million in 2023, then tumbled by 140.52% to -$9.6 million in 2024, then surged by 51.76% to -$4.6 million in 2025, then soared by 149.56% to $2.3 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $2.3 million, -$11.8 million, and -$4.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Mn |
| Mar 31, 2026 | -11.76 Mn |
| Dec 31, 2025 | -4.64 Mn |
| Sep 30, 2025 | 22.39 Mn |
| Jun 30, 2025 | 12.93 Mn |
| Mar 31, 2025 | -37.85 Mn |
| Dec 31, 2024 | -9.62 Mn |
| Sep 30, 2024 | 8.70 Mn |
| Jun 30, 2024 | -21.16 Mn |
| Mar 31, 2024 | 14.20 Mn |
| Dec 31, 2023 | 23.75 Mn |
| Sep 30, 2023 | -60.58 Mn |
| Jun 30, 2023 | -127.57 Mn |
| Mar 31, 2023 | 233.61 Mn |
| Dec 31, 2022 | 16.09 Mn |
| Sep 30, 2022 | 14.90 Mn |
| Jun 30, 2022 | -26.52 Mn |
| Mar 31, 2022 | -15.76 Mn |
| Dec 31, 2021 | -17.07 Mn |
| Sep 30, 2021 | -742,000.00 |